How ERP for Pharma Industry Are Cutting Drug Development Time by 30%
How ERP for Pharma Industry Are Cutting Drug Development Time by 30%
Blog Article
Before directly jumping to how ERP for pharma industry is cutting drug development time, we should first explore the challenges and time-consuming tasks responsible for delays in the drug development process.
From our experience of working with leading pharma manufacturers, we have seen manufacturers face major inefficiencies due to unintegrated data between departments, where research, quality control, and regulatory teams operate on disconnected systems. Also, manual data entry errors create inconsistencies which cause compliance and audit trail issues that again delay approvals.
A lack of real-time collaboration across global teams worsens these challenges, ultimately resulting in high costs and long time due to manual processes. Researchers usually spend up to 25% of their time just managing administrative tasks like data entry, regulatory reporting, and protocol documentation rather than working on actual drug development.
These operating inefficiencies directly impact the time of drug development in the pharma industry. Today, in this article, we will discuss how ERP for pharma industry is helping in reducing drug development time.
ERP for pharma industry